[1]
Healy PJ, Helliwell PS. Classification of the spondyloarthropathies. Current opinion in rheumatology. 2005 Jul:17(4):395-9
[PubMed PMID: 15956834]
Level 3 (low-level) evidence
[2]
Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis care & research. 2013 Aug:65(8):1299-306. doi: 10.1002/acr.21994. Epub
[PubMed PMID: 23436774]
[3]
Bakland G, Nossent HC. Epidemiology of spondyloarthritis: a review. Current rheumatology reports. 2013 Sep:15(9):351. doi: 10.1007/s11926-013-0351-1. Epub
[PubMed PMID: 23888360]
[4]
Bakland G, Alsing R, Singh K, Nossent JC. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27. Arthritis care & research. 2013 Mar:65(3):448-53. doi: 10.1002/acr.21804. Epub
[PubMed PMID: 22833469]
[5]
Baeten D, Breban M, Lories R, Schett G, Sieper J. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis and rheumatism. 2013 Jan:65(1):12-20. doi: 10.1002/art.37829. Epub
[PubMed PMID: 23288559]
[6]
Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. The Journal of rheumatology. 2000 May:27(5):1247-50
[PubMed PMID: 10813295]
[7]
Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's & colitis. 2017 May 1:11(5):631-642. doi: 10.1093/ecco-jcc/jjw199. Epub
[PubMed PMID: 28453761]
Level 1 (high-level) evidence
[9]
Kehl AS, Corr M, Weisman MH. Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment. Arthritis & rheumatology (Hoboken, N.J.). 2016 Feb:68(2):312-22. doi: 10.1002/art.39458. Epub
[PubMed PMID: 26473401]
[10]
Van Mechelen M, Lories RJ. Microtrauma: no longer to be ignored in spondyloarthritis? Current opinion in rheumatology. 2016 Mar:28(2):176-80. doi: 10.1097/BOR.0000000000000254. Epub
[PubMed PMID: 26751839]
Level 3 (low-level) evidence
[11]
Baeten D, De Keyser F. The histopathology of spondyloarthropathy. Current molecular medicine. 2004 Feb:4(1):1-12
[PubMed PMID: 15011954]
[12]
Taurog JD, Chhabra A, Colbert RA. Ankylosing Spondylitis and Axial Spondyloarthritis. The New England journal of medicine. 2016 Sep 29:375(13):1303. doi: 10.1056/NEJMc1609622. Epub
[PubMed PMID: 27682050]
[13]
Weisman MH. Inflammatory back pain: the United States perspective. Rheumatic diseases clinics of North America. 2012 Aug:38(3):501-12. doi: 10.1016/j.rdc.2012.09.002. Epub
[PubMed PMID: 23083751]
Level 3 (low-level) evidence
[14]
Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MH. Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis. The Cochrane database of systematic reviews. 2014 Nov 6:(11):CD010208. doi: 10.1002/14651858.CD010208.pub2. Epub 2014 Nov 6
[PubMed PMID: 25375291]
Level 1 (high-level) evidence
[15]
Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewé R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K, van der Heijde D. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the rheumatic diseases. 2018 Jan:77(1):3-17. doi: 10.1136/annrheumdis-2017-211734. Epub 2017 Jul 6
[PubMed PMID: 28684559]
[16]
van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Annals of the rheumatic diseases. 2017 Jun:76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13
[PubMed PMID: 28087505]